Apr 11, 2019Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality ManagemeAlpha Tau Medical, developer of the breakthrough alpha radiation cancer therapy, Alpha DaRT, announced today that it has obtained ISO...
Jan 31, 2019Alpha DaRT: Turning alpha radiation into a high-precision cancer therapyRadiation therapy, the use of high-energy particles or waves, such as x-rays, gamma rays, electrons, or protons, has long been used to...
Nov 7, 2018Alpha Tau Medical Launches New Clinical Trials in Italy with Leading Cancer Centers, La Sapienza andTrials will investigate the efficacy of its breakthrough cancer treatment, Alpha DaRT, in Squamous Cell Carcinoma (SCC) of the Skin, and...
Sep 5, 2018Israeli MedTech Start-up, Alpha Tau Medical, Raises $29 Million in Private Financing to Cure CancerProceeds to accelerate expansion of global clinical research program and establish new production facilities to meet growing demand for...
Aug 23, 2018New Radiotherapy Approach Deemed Safe for Clinical TrialsThe Massachusetts Radiation Control Program (RCP), in conjunction with the U.S. Nuclear Regulatory Commission (NRC), has approved Alpha...
Jul 17, 2017Alpha Tau Medical Secures Second Funding Round to Treat Solid Tumors with Alpha RadiationFollowing the promising preliminary clinical results, showing the ability of Alpha DaRT to effectively and safely destroy solid tumors,...